azacitidine has been researched along with Sarcoma, Ewing in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, M; Bridge, JA; Frayer, R; Nestheide, S; Sumegi, J | 1 |
| Alholle, A; Arrigoni, E; Avigad, S; Brini, AT; Dallol, A; Gharanei, S; Grimer, R; Hiruma, T; Kishida, T; Latif, F; Maher, ER; Vaiyapuri, S | 1 |
| Borinstein, SC; Hawkins, AG; Laird, PW; Lawlor, ER; Martens, JR; Punj, V; Ryland, KE; Weisenberger, DJ | 1 |
| Glaubiger, DL; LeVine, AS; Poplack, DG; Reaman, GH; Srinivasan, U | 1 |
| Budarf, ML; Emanuel, BS; McDermid, HE | 1 |
| Llombart-Bosch, A; Navarro, S; Noguera, R; Peydró-Olaya, A | 1 |
| Debatin, KM; Dockhorn-Dworniczak, B; Fulda, S; Küfer, MU; Meyer, E; van Valen, F | 1 |
1 trial(s) available for azacitidine and Sarcoma, Ewing
| Article | Year |
|---|---|
Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in Ewing sarcoma.
Topics: Antimetabolites, Antineoplastic; Azacitidine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Male; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Sarcoma, Ewing | 2013 |
6 other study(ies) available for azacitidine and Sarcoma, Ewing
| Article | Year |
|---|---|
RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
Topics: Adolescent; Azacitidine; Cell Line, Tumor; Cells, Cultured; Child; Child, Preschool; Cohort Studies; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Prognosis; Real-Time Polymerase Chain Reaction; Sarcoma, Ewing; Tumor Suppressor Proteins | 2013 |
Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Topics: Azacitidine; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Kv1.5 Potassium Channel; Promoter Regions, Genetic; Sarcoma, Ewing | 2016 |
Phase II study of 5-azacytidine in sarcomas of bone.
Topics: Adolescent; Adult; Azacitidine; Bone Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Platelet Count; Sarcoma, Ewing; Thrombocytopenia | 1982 |
Long-range restriction map of human chromosome 22q11-22q12 between the lambda immunoglobulin locus and the Ewing sarcoma breakpoint.
Topics: Azacitidine; Chromosomes, Human, Pair 22; Dinucleoside Phosphates; DNA-Cytosine Methylases; Electrophoresis, Gel, Pulsed-Field; Humans; Hybrid Cells; Immunoglobulin lambda-Chains; Restriction Mapping; Sarcoma, Ewing; Tumor Cells, Cultured | 1993 |
Patterns of differentiation in extraosseous Ewing's sarcoma cells. An in vitro study.
Topics: Abdominal Neoplasms; Adolescent; Adult; Azacitidine; Bucladesine; Cell Differentiation; Female; Humans; Immunohistochemistry; Infant; Male; Microscopy, Electron; Microscopy, Phase-Contrast; Sarcoma, Ewing; Soft Tissue Neoplasms; Tumor Cells, Cultured | 1994 |
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bone Neoplasms; Caspase 3; Caspase 8; Caspase 9; Caspases; Decitabine; DNA Modification Methylases; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Induction; Gene Transfer Techniques; Humans; Membrane Glycoproteins; Methylation; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; RNA, Messenger; Sarcoma, Ewing; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |